Trademarkia Logo

Australia

AU$
REZDIFFRA
Accepted: Awaiting publication

Last updated on 4 Apr 2025

Owner Info

Madrigal Pharmaceuticals, Inc.

200 Barr Harbor Drive, Suite 200

West Conshohocken PA 19428, UNITED STATES OF AMERICA

Serial Number

2519380 filed on 27 Dec 2024

Correspondent

Anita B. Polott Morgan, Lewis & Bockius LLP

1111 Pennsylvania Avenue, NW,

Washington DC 20004-2541,

UNITED STATES OF AMERICA

REZDIFFRA

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.

Mark Details


Serial Number

2519380

Registered On

NA

Renewal On

NA

Mark Type

WORD

Legal History


Status DateAction Taken
4th Apr 2025Status change to Accepted
6th Feb 2025Awaiting examination
6th Feb 2025IP Right Filed Published
6th Feb 2025Status change to Published
6th Feb 2025Status change to Filed
6th Feb 2025Application Received
6th Feb 2025IP right goods and service classes updated
6th Feb 2025IP Right Goods and Services Items updated
6th Feb 2025Status change to Received
6th Feb 2025Trade mark representation updated